Novanat Bioresource News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Novanat bioresource. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Novanat Bioresource Today - Breaking & Trending Today

Artemisinin Derivatives Market Analysis: To Reach Around USD 1,080 MN In 2027


Artemisinin Derivatives Market Analysis: To Reach Around USD 1,080 MN In 2027
January 29, 2021
|
by
admin
|
The latest market report published by Credence Research, the
Artemisinin Derivatives market was valued at USD 655 million in 2020 and expected to grow at a CAGR of 6.05% during the forecast period from 2021 to 2027 to reach around USD 1,080 million in 2027.
Artemisinin derivatives are a group of active pharmaceutical ingredients which are used in treatment against malaria. Artemisinin and its derivatives effectively fight against malarial and parasitic worm (helminth) infections. They have been proven to be most effective and potential drugs to kill the parasites and its life cycle. Artemisinin is typically derived from the plant Artemisia annua and sweet wormwood. Artemisia annua and sweet wormwood are long been used in traditional Chinese medicines. ....

Burkina Faso , United States , Novanat Bioresource , Asia Pacific , Chris Smith , Scientific Research , Expert Panel , Credence Research , Research Methodology , Shanghai Natural Co , Research Scope , Company Profiles , Sample Copy , Report With Covid , Global Artemisinin Derivatives , Strengthen Demand , Artemisinin Derivatives , Understand How , Artemisinin Derivatives Market , Malaria Treatment , Latin America , North America , Guangxi Xiancaotang Pharmaceutical , Guilin Pharmaceutical , Kerui Nanhai Pharmaceutical , Botanical Extracts ,